Jazz Pharmaceuticals
JAZZ
#2116
Rank
A$11.79 B
Marketcap
$195.13
Share price
-1.17%
Change (1 day)
8.52%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): A$0.58 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$3.99 Billion. In 2023 the company made an earning of A$0.47 Billion, an increase over its 2022 earnings that were of -A$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.58 B21.77%
2023 A$0.47 B-179.92%
2022 -A$0.61 Billion230.37%
2021 -A$0.19 Billion-141.02%
2020 A$0.44 B-39.45%
2019 A$0.73 B-14.2%
2018 A$0.85 B20.03%
2017 A$0.71 B-17.15%
2016 A$0.85 B22.14%
2015 A$0.70 B187.64%
2014 A$0.24 B-50.79%
2013 A$0.49 B73.63%
2012 A$0.28 B41.69%
2011 A$0.20 B116.61%
2010 A$93.05 M262.77%
2009 A$25.65 M-111.33%
2008 -A$0.23 Billion1.31%
2007 -A$0.23 Billion77.8%
2006 -A$0.13 Billion36.59%
2005 -A$92.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$3.86 Billion-699.99%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$3.37 B 425.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.50 B 3,093.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.67 B 5.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel